Schnegg et al34 found that tumour xenografts originated from sensitive to VEGFA inhibition underwent an adaptation via HIF‐1 expression and an increase in CD144+ VM, while tumour xenografts of cell populations resistant to this inhibition did not exhibit these features compared to the control counterparts. This evidence concerns the gene CDH5 and neoplasm.